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Abstract: This study aimed to systematically review previous studies on the reliability and concurrent
validity of the Global Physical Activity Questionnaire (GPAQ). A systematic literature search was
conducted (n = 26) using the online EBSCOHost databases, PubMed, Web of Science, and Google
Scholar up to September 2019. A previously developed coding sheet was used to collect the data.
The Modified Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies was
employed to assess risk of bias and study quality. It was found that GPAQ was primarily revalidated
in adult populations in Asian and European countries. The sample size ranged from 43 to 2657 with a
wide age range (i.e., 15–79 years old). Different populations yielded inconsistent results concerning
the reliability and validity of the GPAQ. Short term (i.e., one- to two-week interval) and long-term
(i.e., two- to three-month apart) test–retest reliability was good to very good. The concurrent validity
using accelerometers, pedometers, and physical activity (PA) log was poor to fair. The GPAQ data
and accelerometer/pedometer/PA log data were not compared using the same measurements in some
validation studies. Studies with more rigorous research designs are needed before any conclusions
concerning the concurrent validity of GPAQ can be reached.
Keywords: adult physical activity questionnaire; international perspective; revalidation
1. Introduction
Participation in physical activity (PA) on a regular basis is well documented as a critical component
of a healthy lifestyle and disease prevention [1]. However, public health organizations, educational
institutions, and others interested in an intervention project should have valid and reliable scales
for measuring PA [2–4]. Without validated PA measurement scales, it is impossible to accurately
assess and monitor the progress of PA interventions fairly and in different settings [5,6]. Although
technologies such as pedometers and accelerometers have increased the objectivity and accuracy of
PA measures [7,8], self-reported survey methods still have the advantage to reach out to a large scale
of the general population due to its low costs [5,9]. To date, several different PA questionnaires have
been developed and validated for use in developed countries [2,6]. These questionnaires are of limited
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scope and scale because most place high importance on leisure time PA [1,2], while people participate
in PA during work and commute rather than in their leisure-time in many developing countries [9–14].
Therefore, there is a need to develop a valid and reliable questionnaire that can accurately measure PA
behaviors across countries [2,6].
The Global Physical Activity Questionnaire (GPAQ), a modified version of the International
Physical Activity Questionnaire (IPAQ) [6], was developed by the World Health Organization (WHO)
in response to a greater interest in the role of PA in health in 2002 [15]. The aim of the GPAQ was
to enhance the IPAQ in cross-cultural settings [2,15–17]. The GPAQ uses a standardized protocol as
surveillance of PA engagement at the population level with self-report and interview-administrated
modes [15,18]. The original version of the GPAQ contained 19 questions with a shorter version later
developed, eliminating three redundant questions, totaling to 16 questions for the most updated
version [6]. The GPAQ has questions revolving around three domains: Occupational, transport-related,
and leisure-time PA [1,2,18]. For each domain, there is a pre-set PA list to help participants recall PA,
which ensures the reliability and validity of the questionnaire [2,6]. Moreover, the GPAQ can also
standardize data collected, focusing on the moderate-to-vigorous PA (MVPA) for work and recreation,
minutes of walking and bicycling for transport only [15]. Noticeably, the GPAQ assesses sedentary
behavior (SB) by collecting minutes spent in sitting activities [15,19,20]. The GPAQ also uses “a typical
week” in its questionnaire about PA that lasts for at least 10 min with the moderate and vigorous
intensity [1,2]. As such, the GPAQ is missing an element that accurately measures light PA embedded
into work and recreational spaces.
The GPAQ has to be reliable, valid, and adaptable across all populations if it is to monitor
PA behaviors and provide global guidelines for future interventions. Hence, many studies have
examined its validity and reliability in the past [1,9,12,19,21,22], yet, no systematic reviews have been
conducted concerning the reliability and validity of the GPAQ across countries since its inception in
2002. Empirical evidence concerning the validity and reliability of the GPAQ would help us better
understand the overall quality of the questionnaire and shed a new light on the GPAQs worldwide
feasibility. The proposed systematic review could also provide a basis for comparison studies using
GPAQ in future research. It is hoped that the gaps uncovered in our knowledge about the GPAQ found
by this review would help identify directions for future research on the topic in different countries.
Thus, this paper aimed to systematically review the GPAQs reliability and concurrent validity found in
previous studies.
2. Materials and Methods
2.1. Selection Criteria
A literature search using PubMed, Google Scholar, Web of Science, and EBSCOhost databases was
conducted to identify pertinent articles using the following keywords: Validity, concurrent validity,
reliability, validation, global physical activity questionnaire, and GPAQ. These databases have been
deemed to have the widest coverage of research articles in education, psychology, sports, PA, health,
and physical education published in English [3,23,24]. Only peer-reviewed journal articles were
selected for review if they fulfilled the following criteria: Written in English, analyzed/discussed the
reliability and/or validity of the GPAQ. References cited by the selected articles were also explored
to ensure that all eligible publications were included for review. The time frame was set from 2002
at GPAQ’s inception to September 2019. Studies using the GPAQ to collect PA data were excluded.
Conference abstracts and papers were also eliminated (see Table 1).
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Table 1. Search keywords and databases used to select articles.
Initial Search: Assessment
Retrieval Database and Search Terms Search Criteria
Article’s title
EBSCOhost: Validity, concurrent validity,
reliability, validation, global physical
activity questionnaire, and Global Physical
Activity Questionnaire (GPAQ)
Peer-reviewed journal articles; written in
English; analyzed/discussed the reliability
and/or validity of the GPAQ; studies using
the GPAQ to collect PA data were excluded;
conference abstracts and papers were
eliminated; articles discussing GPAQ
without actual reliability and validity data
were not selected; time frame was set from
2002 to September 2019.
PubMed: Validity, concurrent validity,
reliability, validation, global physical
activity questionnaire, and GPAQ
Google Scholar: Validity, concurrent
validity, reliability, validation, global
physical activity questionnaire, and GPAQ
Webs of Science: Validity, concurrent
validity, reliability, validation, global
physical activity questionnaire, and GPAQ
2.2. Data Reduction and Harmonization
A coding sheet was first developed based on the purposes of the study and the PRISMA-P
checklist [25]. Previously published systematic review studies on similar topics [5,26,27] were also
examined to help generate the complete coding sheet. The following data were coded: Countries in
which the GPAQ was tested, first author’s name, year of publication, research design, the number of
participants, participants’ mean age, gender, ethnicity, and occupation, comparison devices/methods,
and values of validity and reliability measure(s).
Using the above pre-established inclusion/exclusion criteria, three independent reviewers with a
PA questionnaire validation background initially screened all abstracts of the 391 retrieved articles,
rating each abstract as either yes, no, or maybe for inclusion. The ones rated as yes were kept and those
rated as no by both reviewers were eliminated. The maybe ones were reviewed by a third reviewer
and a consensus was reached through discussion for any disagreement among the three reviewers.
A total of 26 articles met the inclusion criteria and were retrieved for complete review and analysis.
The entire text of each article evaluated was examined by three investigators. The other two authors
served as the reliability coders by independently coding all the 26 articles to ensure the acceptable
inter-coder reliability (agreement > 80%) [28]. Discrepancies between coders were discussed among all
team members until the consensus was reached.
2.3. Methodological Quality and Risk of Bias
The methodological quality and risk of bias of the selected articles were assessed using The
Modified Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies [29], based
on the purpose of the study and the content domains included, ultimately, allowing us to assess
the appropriateness of the methodology, study design, participant selection, and data analysis.
The following two modifications were made. First, instead of using a checklist style (i.e., yes or no),
a three-point Likert scale (i.e., 3 = good, 2 = fair, and 1 = poor) was employed to evaluate the items
included in the aforementioned tool. And second, the content of the assessment tool was also modified
according to previous research on PA questionnaire reliability and validity [3,5]. Specifically, item 13
was not applicable to our paper, and therefore, was deleted. The standards used by Chinapaw et al. [3]
and Hidding [5] were adopted to assess the methodological quality of test–retest reliability studies
regarding the time interval: Between >1 day and <3 months for questionnaires recalling a standard
week, which was used in the GPAQ [6].
Two of the researchers independently rated the articles in each of the items listed in the tool. Since
there were only 26 articles with specific reliability and/or validity data, the raters coded all studies
separately with specific comments on the weaknesses of those studies which were rated poor. The
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results of these ratings were compared, and discrepancies among raters were discussed until 100%
agreement was achieved.
2.4. Synthesis of Results
2.4.1. Reliability
The following types of studies were included for synthesis if it reported intraclass correlation
coefficients (ICC) for continuous measurements of different raters [30], and/or Pearson r for continuous
variable and Spearman’s correlation coefficients (rho) for rank variables, and/or agreement measures
using Cohen’s simple kappa (κ) for binary ratings and weighted κ for two inter-rater agreement
assigning different weights to the different levels [30,31]. It was noted that a single study may
report values of kappa, weighted kappa, and ICC when continuous data are used [32]. According
to Warner [31], the cut-off value of r or rho or κ for poor, moderate (acceptable), or strong is <0.4,
0.4–0.8, and >0.8, respectively. For ICC, the cut-off values are slightly different (i.e., poor: ICC < 0.5,
moderate: 0.5 < ICC < 0.70, good: 0.70 < ICC < 0.90, excellent: ICC > 0.90). Because the sample size
and participant characteristics varied greatly among the selected studies, the mean value of test–retest
reliability was not calculated. Instead, the range of reliability and validity was examined.
2.4.2. Concurrent or Criterion Validity
Concurrent validity is defined as the degree to which the measurement values of the GPAQ
are consistent with a criterion-related standard [4,20,22,32]. The criterion-related standard was
established by both self-reported (i.e., PA log and IPAQ) and objectively measured data (i.e., pedometers
and accelerometers). In general, concurrent validity often tested using Spearman’s rho and the
Bland–Altman plots for visually assessing the absolute agreement between two different methods
when the same variable was measured [28,30]. The mean bias could also be examined using the
Bland–Altman plots. The aforementioned cut-off values for rho were used to assess the magnitude of
concurrent validity. The concurrent validity of three domains of PA and SB was also synthesized.
3. Results
3.1. Article Selection
A total of 26 publications were included in the review (see Figure 1). These studies validated the
GPAQ in 18 independent countries and two in multiple countries from 2002 to September 2019 [1,7,9,
11,12,16,18–20,33–48]. There were five countries (i.e., India [36,46], Malaysia [9,37], Singapore [7,18],
US [20,41–43], and Vietnam [12,43]) with more than one study on the topic, excluding the ones
conducted in multiple countries.
Among these completed in the 18 countries, 10 were in Asian countries (i.e., Bangladesh, China,
India, Korea, Malaysia, Saudi Arabia, Singapore, Thailand, The United Arab Emirates (UAE), and
Vietnam) with a total of 20 publications (i.e., 76.9%). The rest were from European countries and the
US. However, one of the two validation studies was completed in multiple countries reporting the
validation data from nine countries [1]. The other was done in Belgium, Spain, and UK [44].
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Figure 1. Flow chart of articles searched (Note: Some studies examined both reliability and validity
and thereby the total N is greater than 26).
The representation of other continents was limited given that there was one study found in
South America [19] and Africa [39], respectively, even though it was reported that the GPAQ has been
used in many African countries [1,2]. Moreover, only one article included participants who ere
younger than 18 [36]. No studies specifically examined the reliability and validity of the GPAQ in the
elderly group, even though many studies have included participants whose age was above 60 years
old [7,11,12,20,36,40,42,43].
The GPAQ could be administered by others using face-to-face interviews or self-administered [2,
18,47,48]. An interviewer-administered GPAQ requires a trained interviewer, while self-administered
may be more cost-effective, if valid and reliable. Chu and colleagues [18] tested the differences in using
self- and interviewer-administered modes and found a similar level of comparability between the two
administrations (see Table 2).
3.2. Methodological Quality and Risk of Bias
All studies used a cross-sectional research design (see Table 3). The GPAQ data were compared to
accelerometer and/or pedometer data except for one study, which used a PA log [11]. The quality of
study scores ranged from 1 to 3 (i.e., the higher the mean, the better study quality). Methodological
shortcomings were mostly identified as not wearing pedometers or accelerometers during the typical
week in which the GPAQ aimed to measure. A smaller sample size was the second common weakness
noted (see Table 4).
3.3. Concurrent Validity of GPAQ
A cross-sectional research design was employed by all studies. Most selected studies (24 out of 26)
examined the concurrent validity of the GPAQ by comparing the weekly GPAQ data with a criterion
measure(s). Eight studies used pedometer and/or a PA log and/or IPAQ data as the criterion measure
while the rest of the studies used either accelerometers or pedometers (Note: Some studies used more
than one criterion standard) (see Tables 5–7). Spearman’s rho was calculated to examine criterion
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validity. Bland–Altman plots were also used to test the acceptable agreement between the two sets
of data.
Concurrent Validity Results
As noted earlier, the GPAQ data were compared to either accelerometers and/or pedometers and/or
a PA log and/or a previously validated PA questionnaire (e.g., IPAQ). Data collected by ActiGraph
GT3X (AG) was most often employed in the validation studies (see Table 5). Criterion validity for the
overall PA, the three PA domains, and SB, respectively, was examined. The concurrent validity for
work-related PA (r: −0.03–0.50), transport-PA (r: 0.04–0.49), and leisure-PA (r: 0.02–0.41) was poor to
fair. So was the SB concurrent validity (r: 0.07–0.47). In addition, MVPA concurrent validity using
accelerometers was mostly often investigated, followed by moderate PA (MPA) and vigorous PA (VPA).
Specifically, MVPA concurrent validity using accelerometers and pedometer, PA log and IPAQ was
−0.01–−0.69, and −0.01–−0.54, respectively. In essence, the results of the criterion validity for various
GPAQ measures ranged from poor to fair using Spearman’s rho (see Tables 5–7).
The concurrent validity results using both pedometers and accelerometers, surprisingly, were
about the same (r < 0.5), even though accelerometers are found to generate more accurate PA data
than pedometers [45]. Moreover, pedometers only measure steps without PA intensity data. However,
different total daily steps were used to indirectly measure PA with different intensities. For instance,
Sitthipornvorakul and colleagues [32] classified pedometer (steps/day) inactive (<5000), moderately
active (5000–9999), and highly active (≥10,000). This was how pedometer data quantified the PA
intensity (see Table 6). PA domain-specific concurrent validity of the GPAQ was also poor to fair
compared to that measured by accelerometers, pedometers, or a PA log. There was only one study
using the IPAQ that found very good concurrent validity of the GPAQ in India [36].
When the GPAQ was analyzed on a country level, each country had a slightly different result.
For instance, using the same method by comparing GPAQ data with AG accelerometer data, some
researchers reported higher correlations for minutes of MVPA in the US (r = 0.26) [42], China (r =
0.26–0.52) [11], and the UK (r = 0.48) [16] than that found by Bull and colleagues [1] in lower-income
countries such as South Africa (r = −0.03). Moreover, Bland–Altman plots found that participants
tended to overestimate their MVPA and underestimate their SB using the GPAQ.
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Table 2. Descriptions of included studies.
Country First Author, Year Research Design
Participants Data Collection Measures
Bangkok (Thailand) Sitthipornvorakul et al. 2014[32]
320 office workers; aged 34.8 ± 6.2 years; 20%
male
PA assessed by Yamax Digiwalker CW-700 pedometer for
seven days and by GPAQ.
Concurrent validity: ICC for correlation
between GPAQ and pedometer data.
Bangladesh Mumu et al. 2017 [34] 162 healthy adults; aged 35 ± 9 years; 54% female Seven-day wearing AG, then answered GPAQ in aface-to-face interview.
Concurrent validity: Spearman’s rho between
GPAQ and accelerometer indicators.
Chile Aguilar-Farias et al. 2017 [19] 217 adults; aged 43.77 ± 15.75 year; 42.9% male Seven-day wearing AG; face-to-face interview GPAQ singlequestion about sedentary behavior.
Concurrent validity (Spearman correlation)
between AG and GPAQ.
China Hu et al. 2015 [11] 205 adults; aged 30–70 years; 38.54% male Completed three questionnaires twice (Day 1 and Day 9), aPA-log for seven days.
Test–retest reliabilities: Using intra-class
correlation coefficients (ICC);
Relative validities: Comparing the data from
PA questionnaires and PA-log.
France Rivière et al. 2018 [35] 92 adults (56.5% students; 43,5% staff in amedical school); age >18; 27.2% male
Seven-day wearing AG, complete GPAQ before and after
wearing AG.
Reliability and criterion and concurrent
validity of GPAQ against AG.
India
Misra et al. 2014 [36] 234 participants; age 15–74 years; 49.6% male Test–retest repeatability of GPAQ, IPAQ, and pedometer. Spearman’s rho, ICC for validity and reliability.
Mathews et al. 2016 [45] 47 adults; aged 18–64 years; 100% female Using AG to validate the self-polished modified GPAQ. Concurrent validity (Spearman’s rho) and ICC
Korea Lee et al. 2019 [46]
115 for reliability (55 males and 60 females), age
19–75 years;
199 adults for validity (82 males and 117 females)
Completed GPARQ twice with seven days apart;
Seven-day wearing AG, complete GPAQ after wearing AG.
Test–retest reliability and criterion-related
validity (Spearman’s rho)
Malaysia
Lingesh et al. 2016 [9] 43 nurses; aged 24 to 55 years (44.48 ± 8.38years); 100% female
IPAQ and GPAQ: Measured on the eighth day, and wore
SenseWear accelerometer and recorded PA logs for seven
consecutive days.
PA data measured by PA logs for seven days;
METs-min/week−1 was used; Pearson
correlations and a Bland–Altman plot.
Soo et al. 2015 [37] 100 adults; aged 20–58 years; 83% female By comparing GPAQ-M with IPAQ-S and objectivelymeasuring PA using a Yamax DigiWalker pedometer.
Two-week test–retest reliability: Using the
Wilcoxon signed-rank analysis;
concurrent validity: Spearman’s rho by
comparing GPAQ-M data with IPAQ and
objectively measured PA data.
Saudi Arabia Alkahtani, 2016 [38] 62 college students; aged 19–21 years (20.0 ± 1.1year); 100% male
Completed GPAQ twice (two weeks apart) and wore AG for
seven consecutive days.
Test–retest reliability and concurrent validity
of the GPAQ with AG using Spearman’s rho.
Singapore Chu et al. 2015 [18]
110 working adults and students; aged 31
(26.8–47.3); 70.9% female
Self- and interviewer-administration of GPAQ, seven days
of AG.
Test–retest reliability with one-week interval;
criterion validity with Spearman’s ICC.
Chu et al. 2018 [7] 84 medicine faculty and staff at a university;aged 21–65 years; 69% female
Single sitting item of GPAQ using self- and
interviewer-administered modes twice with seven days
apart, seven days of AG.
Reliability using the Spearman’s rho and ICC;
Convergent validity using Spearman’s rho.
South Africa Watson et al. 2017 [39] 95 pregnant women, aged 29.5 ± 5.7 years
Data collected at 14–18 weeks and 29–33 weeks’ gestation;
seven-day wearing AG; comparing total time in MVPA
between GPAQ and AG.
Content validity, convergent validity in
comparison with AG; relative validity.
Spain Ruiz-Casado et al. 2016 [40] 204 cancer survivors; aged 18–79 years; 36% male Comparing IPAQ-SF and GPAQ with AG; AG was worn for5 to 10 days.
Validity: Wilcoxon signed-rank was used to
compare the differences between questionnaire
and accelerometry data.
Switzerland Wanner et al., 2017 [47] 354 (physical activity) and 366 (sitting), age18–83 years Completed GPAQ on Day 1, then wore AG for seven days. Concurrent validity (Spearman correlation)
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Table 2. Cont.
Country First Author, Year Research Design
Participants Data Collection Measures
The United Arab
Emirates (UAE) Doyle et al. 2019 [48] 93 university students;
Completing GPAQ-A on two occasions (seven days apart);
wearing an accelerometer for seven days. Test–retest reliability and criterion validity
UK Cleland et al. 2014 [16] 101 adults; aged 44 ± 14 years; 54% male
Wore AG for seven days and completed GPAQ on Day 7;
Repeated for a random sub-sample at three to six months
later.
Wilcoxon-signed rank tests for differences in measures;
Spearman’s rho coefficient for criterion validity and
extent of change.
US
Gorzelitz et al. 2018 [41] 347 adults; aged 50.7 ± 16.9 years; 46.7% male Wore AG for seven days; GPAQ face-to-face interviewsself-reported data.
MVPA data measured by both GPAQ and AG; MVPA
converted into METs.
Herrmann et al. 2013 [42]
Study 1: 69 adults; aged 43.1 ± 11.4 years; 82.6%
female; Study 2: 16 adults; aged 40.2 ± 12.6 years;
50% female
First study for long-term test–retest reliability with three
moths apart, completed GPAQ and worn ActiGraph GT1M
accelerometer for seven days;
Second study for short-term test–retest reliability with 10
days apart.
ICC for reliability; weighted Cohen’s K and percent
agreement for testing validity with categorical scores
(IPAQ vs. GPAQ);
Spearman’s rho for validity with numerical variables.
Hoos et al. 2012 [43] 72 Latinas; aged 43.01 ± 9.05 years; 58% female Worn accelerometer for seven days at the baseline and sixmonths later; GPAQ data collected at the same time.
GPAQ’s sensitivity to intervention change using
Spearman’s rho for concurrent validity.
Metcalf et al. 2018 [20] 108 residents; aged 49.4 years (range: 19.8–68.7);68.5% female
Seven-day wearing AG followed by a telephone interview
of GPAQ.
Multivariable linear regression models using functions
of the GPAQ data to predict AG measured physical
activity and sedentary behavior.
Vietnam
Thuy et al. 2010 [22] 251 adults; aged 25–64 years; 50.6% female
GPAQ and IPAQ were administered face-to-face, then wore
a pedometer and complete PA log for seven consecutive
days.
Reliability of GPAQ and IPAQ for groups;
Concurrent validity was assessed from the correlations
between pedometer steps per day and IPAQ.
Trinh et al. 2009 [12] 169 adults; aged 25–64 years; 48.5% male
GPAQ was administered twice in the dry and wet season
two weeks apart, respectively; wore the accelerometer twice
for seven days during the week before the first and last
GPAQ administration.
Spearman’s rho for the repeatability of the GPAQ,
weighted Cohen’s Kappa for reliability;






Bull et al. 2009 [1] 2657 adults from nine countries; aged 18–75years; 61.3% male
Ten projects were initiated in 2002–2003 through WHO
headquarters and regional offices and other known
networks.
Test–retest reliability of GPAQ for categorical variables
using Cohen’s Kappa and Spearman’s rho for
continuous variables;
Concurrent validity with IPAQ and
pedometer/accelerometer data using Spearman’s rho.
Belgium, Spain, UK Laeremans et al. 2017 [44] 122 adults; aged 35 ± 10 years; 45% males
Seven-day wearing SenseWear armband and complete
GPAQ online on the final day; adjusted GPAQ to capture
information on walking, cycling and e-biking trips
separately for the travel to and from work subscale; three
trials for the same data collection.
Reliability: The changes in the difference between two
methods over three trials; energy expenditure and
minutes spent in MVPA, MPA, VPA and sedentary
behaviors;
Validity: Wilcoxon signed rank-sum test, Spearman
correlation coefficients, mixed-effects regression
models and Bland–Altman plots.
Note: AG = accelerometer Actigraph GT3X; GPAQ = Global Physical Activity Questionnaire; GPAQ-A = Global Physical Activity Questionnaire-Arabic Version; ICC = intraclass correlation
coefficient; IPAQ-SF = International Physical Activity Questionnaire-Short Form; LoA = limits of agreement; MVPA = moderate-to-vigorous physical activity; MPA = moderate physical
activity; VPA = vigorous physical activity.
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Table 3. Means of methodological quality assessment.
Assessment Questions Article by Author
Aguilar-Farias













1. Was the research question or objective in this paper clearly stated? 3 3 3 3 3 3 3
2. Was the study population clearly specified and defined? 3 3 2 2 3 2 2
3. Was the participation rate of eligible persons at least 50%? 3 3 3 3 3 3 2
4. Were all the subjects selected or recruited from the same or similar populations (including
the same time period)? Were inclusion and exclusion criteria for being in the study
prespecified and applied uniformly to all participants?
2 2 1 2 3 2 2
5. Was a sample size justification, power description, or variance and effect estimates
provided? 1 3 1 3 3 1 1
6. For the analyses in this paper, was the exposure(s) of interest measured prior to the
outcome(s) being measured? 3 3 3 3 3 3 3
7. Was the timeframe sufficient so that one could reasonably expect to see an association
between exposure and outcome if it existed? 3 3 3 3 3 3 2
8. For exposures that can vary in amount or level, did the study examine different levels of
the exposure as related to the outcome (e.g., categories of exposure, or exposure measured as
a continuous variable)?
3 3 3 3 3 3 3
9. Were the exposure measures (independent variables) clearly defined, valid, reliable, and
implemented consistently across all study participants? 3 3 3 3 3 2.5 2.5
10. Was the exposure(s) assessed more than once over time? 1 3 3 2.5 3 3 2
11. Were the outcome measures (dependent variables) clearly defined, valid, reliable, and
implemented consistently across all study participants? 2.5 3 3 3 3 3 3
12. Were the outcome assessors blinded to the exposure status of participants? 3 3 3 3 3 3 3
13. Were key potential confounding variables measured and adjusted statistically for their
impact on the relationship between exposure(s) and outcome(s)? 2.5 3 3 3 3 2 1.5
Average score 2.5 2.9 2.6 2.8 3 2.6 2.3
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Table 3. Cont.
















1. Was the research question or objective in this paper clearly stated? 3 3 3 3 3 3 3
2. Was the study population clearly specified and defined? 3 2 3 3 2 3 3
3. Was the participation rate of eligible persons at least 50%? 3 1 3 3 3 3 3
4. Were all the subjects selected or recruited from the same or similar populations (including
the same time period)? Were inclusion and exclusion criteria for being in the study
prespecified and applied uniformly to all participants?
3 2 3 3 2 2 2
5. Was a sample size justification, power description, or variance and effect estimates
provided? 2 1 3 1 1 1.5 1
6. For the analyses in this paper, was the exposure(s) of interest measured prior to the
outcome(s) being measured? 3 2 3 3 3 3 3
7. Was the timeframe sufficient so that one could reasonably expect to see an association
between exposure and outcome if it existed? 3 3 3 3 3 3 3
8. For exposures that can vary in amount or level, did the study examine different levels of
the exposure as related to the outcome (e.g., categories of exposure, or exposure measured as
a continuous variable)?
3 2 3 3 3 2 3
9. Were the exposure measures (independent variables) clearly defined, valid, reliable, and
implemented consistently across all study participants? 3 3 3 3 3 2 3
10. Was the exposure(s) assessed more than once over time? 3 1.5 3 3 3 1 3
11. Were the outcome measures (dependent variables) clearly defined, valid, reliable, and
implemented consistently across all study participants? 3 3 3 3 3 2 3
12. Were the outcome assessors blinded to the exposure status of participants? 3 3 3 3 3 3 3
13. Were key potential confounding variables measured and adjusted statistically for their
impact on the relationship between exposure(s) and outcome(s)? 3 1.5 3 3 3 3 3
Average score 2.8 2.2 3 2.8 2.7 2.4 2.8
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Table 3. Cont.















et al. 2014 [32]
1. Was the research question or objective in this paper clearly stated? 3 3 3 3 3 3 3
2. Was the study population clearly specified and defined? 2 3 1 3 3 3 2
3. Was the participation rate of eligible persons at least 50%? 2 3 3 3 3 3 1
4. Were all the subjects selected or recruited from the same or similar populations (including
the same time period)? Were inclusion and exclusion criteria for being in the study
prespecified and applied uniformly to all participants?
1 3 1 2 2 3 3
5. Was a sample size justification, power description, or variance and effect estimates
provided? 1 1 1 1 1 1 1
6. For the analyses in this paper, was the exposure(s) of interest measured prior to the
outcome(s) being measured? 1 3 3 3 3 3 3
7. Was the timeframe sufficient so that one could reasonably expect to see an association
between exposure and outcome if it existed? 2 3 3 3 3 1.5 1
8. For exposures that can vary in amount or level, did the study examine different levels of
the exposure as related to the outcome (e.g., categories of exposure, or exposure measured as
a continuous variable)?
2 3 2 3 3 3 1.5
9. Were the exposure measures (independent variables) clearly defined, valid, reliable, and
implemented consistently across all study participants? 2 3 3 3 3 3 2
10. Was the exposure(s) assessed more than once over time? 1 3 3 1 3 1 2
11. Were the outcome measures (dependent variables) clearly defined, valid, reliable, and
implemented consistently across all study participants? 2.5 3 2.5 3 3 3 3
12. Were the outcome assessors blinded to the exposure status of participants? 2 3 3 3 3 3 3
13. Were key potential confounding variables measured and adjusted statistically for their
impact on the relationship between exposure(s) and outcome(s)? 2 3 3 3 3 3 1
Average score 1.8 2.8 2.4 2.6 2.8 2.6 2.0
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Table 3. Cont.
Assessment Questions Article by Author









2017 [39] - -
1. Was the research question or objective in this paper clearly stated? 3 3 3 3 3
2. Was the study population clearly specified and defined? 3 2 3 3 3
3. Was the participation rate of eligible persons at least 50%? 3 3 3 3 3
4. Were all the subjects selected or recruited from the same or similar populations (including
the same time period)? Were inclusion and exclusion criteria for being in the study
prespecified and applied uniformly to all participants?
3 2 2 3 3
5. Was a sample size justification, power description, or variance and effect estimates
provided? 2 1 1 2 2.5
6. For the analyses in this paper, was the exposure(s) of interest measured prior to the
outcome(s) being measured? 3 3 3 3 3
7. Was the timeframe sufficient so that one could reasonably expect to see an association
between exposure and outcome if it existed? 3 3 3 3 3
8. For exposures that can vary in amount or level, did the study examine different levels of
the exposure as related to the outcome (e.g., categories of exposure, or exposure measured as
a continuous variable)?
3 3 3 3 3
9. Were the exposure measures (independent variables) clearly defined, valid, reliable, and
implemented consistently across all study participants? 3 2 3 3 3
10. Was the exposure(s) assessed more than once over time? 3 3 3 3 3
11. Were the outcome measures (dependent variables) clearly defined, valid, reliable, and
implemented consistently across all study participants? 3 2.5 3 3 2
12. Were the outcome assessors blinded to the exposure status of participants? 3 3 3 3 3
13. Were key potential confounding variables measured and adjusted statistically for their
impact on the relationship between exposure(s) and outcome(s)? 3 3 3 2 3
Average score 2.9 2.6 2.8 2.8 2.8
Note: Score scale: Strong = 3, Good = 2, Weak = 1.
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Table 4. Results of methodological weaknesses.
Country Studies Methodological Weaknesses
Bangkok (Thailand) Sitthipornvorakul et al. 2014 [32]
The Yamax Digiwalker CW-700 pedometer was removed when immersing the body in water; participants who had four instead of seven daily
measurements were also included in the study; PA intensities were classified using pedometer steps; there is a lack of information on whether the
pedometer data were collected during a typical week when GPAQ data were measured.
Bangladesh Mumu et al. 2017 [34]
Water-based activities were excluded, resulting in underestimates of PA by the accelerometer; participants who wore the accelerometer for ≥3 days
were also included; there is a lack of information on whether the accelerometer data were collected during a typical week when GPAQ data were
measured.
Chile Aguilar-Farias et al. 2017 [19] The accelerometer data were not measured during a typical week when GPAQ data were measured.
China Hu et al. 2015 [11] Self-reported PA log data were used as the criterion-referenced standards for GPAQ data; there is a lack of information on whether the accelerometerdata were collected during a typical week when GPAQ data were measured.
France Rivière et al. 2018 [35] Less than 100 participants were recruited.
India
Misra et al. 2014 [36] Pedometers was used as the criterion-referenced standard.
Mathews et al. 2016 [45] Less than 100 participants were recruited (n = 47 women); total PA was not measured; there is a lack of information on whether the accelerometerdata were collected during a typical week when GPAQ data were measured
Korea Lee et al. 2019 [46] There is a lack of information on whether the accelerometer data were collected during a typical week when GPAQ data were measured
Malaysia
Lingesh et al. 2016 [9] Less than 100 participants were recruited (n = 43 females only); there is a lack of information on whether the accelerometer data were collectedduring a typical week when GPAQ data were measured.
Soo et al. 2015 [37] Pedometers were used as the criterion-referenced standard; average pedometer steps were compared to GPAQ min. data; there is a lack ofinformation on whether the pedometer data were collected during a typical week when GPAQ data were measured.
Saudi Arabia Alkahtani, 2016 [38] Only 62 male participants were recruited; those who wore an accelerometer for ≥4 days were included; there is a lack of information on whether theaccelerometer data were collected during a typical week when GPAQ data were measured.
Singapore Chu et al. 2015 [10] There is a lack of information on whether the accelerometer data were collected during a typical week when GPAQ data were measured.
Chu et al. 2018 [7] Only 78 participants were involved in the study with 69.0% of females; there is a lack of information on whether the accelerometer data werecollected during a typical week when GPAQ data were measured.
South Africa Watson et al. 2017 [39] 95 pregnant women were recruited; there is a lack of information on whether the accelerometer data were collected during a typical week whenGPAQ data were measured.
Spain Ruiz-Casado et al. 2016 [40] There is a lack of information on whether the accelerometer data were collected during a typical week when GPAQ data were measured.
Switzerland Wanner et al. 2017 [47] There is a lack of information on whether the accelerometer data were collected during a typical week when GPAQ data were measured.
UAE Doyle et al. 2019 [48] Less than 100 participants were recruited (n = 93 for reliability study, n = 43 for concurrent validity study); there is a lack of information on whetherthe accelerometer data were collected during a typical week when GPAQ data were measured.
UK Cleland et al. 2014 [16] There is a lack of information on whether the accelerometer data were collected during a typical week when GPAQ data were measured.
US
Gorzelitz et al. 2018 [41] There is a lack of information on whether the accelerometer data were collected during a typical week when GPAQ data were measured.
Herrmann et al. 2013 [42] Only 68 participants were included; there is a lack of information on whether the accelerometer data were collected during a typical week whenGPAQ data were measured.
Hoos et al. 2012 [43] Less than 100 participants (n = 72) were included; there is a lack of information on whether the accelerometer data were collected during a typicalweek when GPAQ data were measured.
Metclif et al. 2018 [20] There is a lack of information on whether the accelerometer data were collected during a typical week when GPAQ data were measured.
Vietnam
Thuy et al. 2010 [22] Accelerometer data were not collected during a typical week.
Trinh et al. 2009 [12] Accelerometer data were not collected during a typical week.
Bangladesh, Brazil, China, Ethiopia,
India, Indonesia, Japan, Portugal,
and South Africa
Bull et al. 2009 [1] Accelerometer or pedometer data were not collected during a typical week.
Belgium, Spain, UK Laeremans et al. 2017 [44] Accelerometer data were not collected during a typical week.
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Table 5. Summary of concurrent validity of GPAQ with accelerometers in various countries.
Country
(1st Author, Year)
Sample Size GPAQ Measures
Sitting MPA VPA MVPA Work Transport Leisure
Bangladesh (Mumu et
al. 2017 [34])
162 healthy adults, age =
35 ± 69 years r = 0.23 **
r = 0.18 *, 0.24 * (CPM),
0.28 ** (step)
65 from urban r = 0.07 r= 0.46 **, 0.55 ** (CPM),0.63 ** (step)
r = 0.38 **, 0.50 ** (CPM),
0.55 ** (step)
r = 0.49 **, 0.46 ** (CPM),
0.52 ** (step)
r = 0.26 *, 0.29 * (CPM),
0.41 ** (step)
97 from rural areas r = 0.38 ** r = 0.0001, −0.01 (CPM),0.05 (step)
r = −0.03, 0.02 (CPM),
0.07 (step)
r = −0.20 *, −0.23 * (CPM),
−0.13 (step)
r = 0.02, −0.05 (CPM),
−0.12 (step)
70 men r = −0.10, 0.04 (CPM),0.05 (step)
85 women r = 0.42 **, 0.46 ** (CPM),0.49 ** (step)
93 (≤35 years) r = 0.31 *, 0.32 ** (CPM),0.34 ** (step)
62 (>35 years) r = −0.03, 0.10 (CPM),0.19 (step)
30 illiterates r = 0.27, 0.35 (CPM), 0.22(step)
37 primary school r = 0.23, 0.20 (CPM), 0.38* (step)
61 high school r = −0.01, 0.01 (CPM), 05(step)
Chile (Aguilar-Farias
et al. 2017 [19])
217, age = 43.77 ± 15.75
years
r = 0.23 ***(1-min), 0.26 *** (5-min),
0.26 *** (10-min); LoA = −768.9 to
181.2 (1-min), −200.4 to 137.1
(5-min), −539.5 to 387.3 (10-min);
Poor in classifying sedentary
behavior into tertiels for 1-, 5- and
10-min bouts: Agreement = 43.5%,
46.0%, 42.2%; k = 0.18, 0.19, 0.13;
and quartiles: Agreement = 31.3%,
32.7%, 31.3%; k = 0.08, 0.10, 0.08
≥ 45 and < 45 years (n:
N/A) r = 0.38 *** (≥45); 0.10 (<45)
93 men and 124 women r = 0.23 * (men); 0.21 * (women)
66 (≥12 years of
education) and 151(<12
years)




and sitting work (n not
provided)
r = 0.26 *** (balanced standing and
sitting); −0.02 (mostly standing)
France (Rivière et al.
2018 [35])
92 students and staff in a
medical school, age >18
years
r = 0.42 **; LoA = 90.1 to 412.3
min/week r = 0.10
r = 0.38 **; LoA
= 286.5 to 601.3
min/week




Sample Size GPAQ Measures
Sitting MPA VPA MVPA Work Transport Leisure
Korea (Lee et al. 2019 [46])
199 adults, 82 males and
117 females r = 0.18 ** r = 0.33 ** r = 0.10 r = 0.34 **
170 adults age 19–64 r = 0.19 * r = 0.37 ** r = 0.09 r = 0.36 **
29 elders age >64 r = 0.08 r = 0.33 r = −0.02 * r = 0.38 *
India (Misra et al. 2014 [36]) 116 males and 118 females;age 15–65 years; r = 0.29 **
r = 0.36 * (step); r = 0.31 *
(male, step), 0.40 *
(female, step)
India (Mathews et al. 2016 [45]) 47 women, age 18–64 years
r = 0.69 (non-bouted),
0.60 (10-min bouts); ICC
= 0.78 (non-bouted), 0.55
(10-min bouts)
Malaysia (Lingesh et al. 2016 [9])
43 female nurses
aged 24 to 55 years
(mean: 44.48 ± 8.38)
r = −0.11
Saudi Arabia (Alkahtani, 2016 [38]) 62 male college students,aged 19–21 years old r = 0.08 r = 0.24 r = 0.32 ** r = 0.32 *
Singapore (Chu et al. 2015 [10])
110 working adults and
students
r = 0.36 *** (total), 0.20
(10-min bouts); LoA =
−115.0 to 121.0 (total);
−88.7 to 148.1 (10-min
bouts)
r = 0.45 *** (total), 0.39 ***
(10-min bouts); LoA =
−46.2 to 99.9 (total), 46.5
to 102.1 (10-min bouts)
(10-min bouts)
r = 0.39 *** (total), 0.37 ***
(10-min bouts); LoA =
−138.7 to 210.4 (total),
−84.8 to 199.8 (10-min
bouts)
52 self-administrated r = 0.28 * (total), 0.29 *(10-min bouts)
r = 0.35 * (total), 0.38 **
(10-min bouts)
r = 0.32 * (total), 0.30 *
(10-min bouts)
56 interview-administrated r = 0.44 *** (total), 0.42 ***(10-min bouts)
r = 0.43 *** (total), 0.52 ***
(10-min bouts)
r = 0.44 *** (total), 0.46 ***
(10-min bouts)
Singapore (Chu et al. 2018 [7])
84 medicine faculty and
staff, aged 21–65 years r = 0.28 *
84 medicine faculty and
staff, aged 21–65 years
37 self-administrated and
41 interview-administrated r = 0.46 * (self), 0.12 (interview)
South Africa (Watson et al. 2017 [39])
95 pregnant women at
14–18 and 29–33 weeks’
gestation, age = 29.5 ± 5.7
years
ICC = 0.08 (14–18 weeks), 0.01
(29–33 weeks); poor agreement in
categorizing active/inactive
participants, k = 0.11 (14–18
weeks), −0.02 (29–33 weeks)
ICC = 0.05 (14–18 weeks),
−0.05 (29–33 weeks); poor
agreement in classifying
PA to quartiles, k = 0.09
(14–18 weeks), −0.03
(29–33 weeks)
Spain (Ruiz-Casado et al. 2016 [40]) 204 cancer survivors aged18–79 years r = 0.17 *; LoA = −4400 to 425
r = −0.03; LoA = −911 to
1395
r = 0.73 ***; LoA = −60 to
75




Sample Size GPAQ Measures
Sitting MPA VPA MVPA Work Transport Leisure
UAE (Doyle et al.
2019 [48])
43 Arabic speaking
university students r = −0.02 r = 0.23
UK (Cleland et al.
2014 [16])
95 participants, age = 44
± 14 years; 44 females, 51
males
r = 0.187 ***; low extent of change
over 3–6 months, r = −0.024 *; r =
0.378 * (women), −0.053 (men)
r = 0.484 ***; moderate
extent of change over 3–6
months, r = 0.52 *; r =
0.434 * (women), 0.496 **
(men)
Switzerland (Wanner
et al., 2017 [47])
354 (physical activity)
and 366 (sitting), age
18–83 years
r = 0.47 *** r = 0.16 ** r = 0.46 *** r = 0.22 (CPM) ***, 0.25 ***(steps); 0.11 * (min/week) r = −0.13 * r = 0.15 **
USA (Gorzelitz et al.
2018 [41])





by sex, education level
and marital status
USA (Herrmann et al.
2013 [42])
54, age = 43.1 ± 11.4
years) r = 0.12 r = 0.36 ** r = 0.39 ** r = 0.26 *
USA (Hoos et al. 2012
[43])
Vietnam
(Trinh et al. 2009 [12])
72 Latinas, aged 18–65
years (mean = 43.01 ±
9.05 years)
r = 0.28 (pre), 0.25 (post) r = 0.04 (pre),0.04 (post)
r = 0.42 ** (pre),
0.24 (post) r = 0.14 (pre), −0.06 (post)
r = −0.17 (pre, MVPA),
−0.15 (pre, MPA), 0.03
(pre, VPA):
r = −0.21 (post MVPA),
−0.10 (post, MPA), −0.19
(post, VPA)
r = 0.24 ** (pre, MPA); r =
0.04 (post, MPA)
169 aged 25–64 years
(44.7 ± 11.1 years)
r = 0.23 (dry season), 0.32(wet
season)
r = 0.18 (dry),
0.10 (wet)
r = −0.04 (dry),
0.03 (wet)
r = 0.20 (dry, MVPA), 0.09
(wet, MVPA); r = 0.34
(dry, total counts), 0.20
(wet, total counts)
Belgium, Spain, UK
(Laeremans et al. 2017
[44])
122 adults (41 Belgium,
41 Spain, 40 UK); 45%
males, age: 35 ± 10 years
r = 0.12 (0.09–0.24 **) r = 0.33(0.11−0.34 **)
r = 0.64 (0.59
***–0.69 **) r = 0.65 (0.55 ***–0.64 ***)
Note: * p < 0.05; ** p < 0.01; *** p < 0.001; CPM = counts per minute; ICC = intraclass correlation coefficient; IPAQ-SF = International Physical Activity Questionnaire; LoA = limits of
agreement; MVPA = moderate-to-vigorous physical activity; MPA = moderate physical activity; VPA = vigorous physical activity.
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Table 6. Summary of concurrent validity of MVPA measured by GPAQ with pedometers in various countries.
Country
(1st Author, Year)
Sample Size GPAQ Measures
Sitting Time Steps/Day MVPA
Bangkok (Sitthipornvorakul et al.
2014 [32])
320 office workers r = 0.08
By age: 77 (20–29 years), 115
(30–39 years), and 88 (over 40
years)
r = 0.27 * (20–29 years), −0.01
(30–39 years), 0.09 (40+ years) a
Malaysia (Soo et al. 2015 [37]) 100 aged 20–58 years r = 0.265 *
Vietnam (Thuy et al. 2010 [22])
120 men and 118 women; by
work pattern: 146 with stable
and 92 with unstable work
patterns;
Men with table job: r = 0.42,
unstable job: r = 0.22; Women
with stable job: r = 0.33,
unstable job: r = 0.16
Bangladesh, Brazil, China, Ethiopia,
India, Indonesia, Japan, Portugal, and
South Africa
(Bull et al. 2009 [1])
2657 male and female adults
from 9 countries; n = 1951 for
criterion validity
r = −0.20 **, ranging from 0
(Japan) to −0.37 (Taiwan, China)
r = 0.31 ** (excluding China,
Brazil, Portugal, South Africa),
ranging from 0.06 (Bangladesh)
to 0.35 (India)
980 males and 971 females; 1077
with fewer than 13-year
education and 298 with more
than 13-year education
Similar criterion validity
between genders and between
low and high education level.
976 from urban areas and 819
from rural areas r = 0.23(urban), 0.43(rural)
406 underweight, 932 healthy
weight, and 262
overweight/obese
r = 0.52 (underweight), 0.34
(healthy BMI), 0.08
(overweight/obese)
Note: * p < 0.05; MVPA = moderate and vigorous physical activity; a = PA intensity was classified by the total daily steps. BMI = body mass index.
Int. J. Environ. Res. Public Health 2019, 16, 4128 18 of 27






Sitting MPA VPA MVPA
China (Hu et al. 2015 [11]) 205 aged 30–70 years, 38.54% ofmales PA log r = 0.52 **
r = 0.47 **;
0.43 ** (MPA
excluding walking)
r = 0.41 ** r = 0.51 **
India (Misra et al. 2014 [36]) 262 aged 15–65 years, 116 males(49.6%) IPAQ r = 0.999 *** r = 0.894 *** r = 0.934 *** r = 0.939 ***
Malaysia (Lingesh et al. 2016 [9])
43 female nurses
aged 24 to 55 years
(44.48 ± 8.38 years)
PA Log r = −0.015
IPAQ r = 0.214
Malaysia (Soo et al. 2015 [37]) 100 aged 20–58 years IPAQ r = 0.447 *** r = 0.459 *** r = 0.466 *** r = 0.309 **
Vietnam (Thuy et al. 2010 [22])
251 (120 men and 118 women)
PA Log r = 0.49 (men), −0.05(women)
IPAQ r = 0.39 (men), 0.18(women)
By work pattern: 146 with stable and
92 with unstable work patterns
PA Log r = 0.31 (stable)
IPAQ r = 0.32 (stable)
Bangladesh, Brazil, China, Ethiopia,
India, Indonesia, Japan, Portugal,
and South Africa (Bull et al. 2009 [1])
2657 male and female adults from
nine countries; n = 1951 for criterion
validity
IPAQ




85.2%, k = 0.22
r = 0.45 ** r = 0.57 ** r = 0.54 **
Note: ** p < 0.01; *** p < 0.001; MVPA = moderate-to-vigorous physical activity; MPA = moderate physical activity; VPA = vigorous physical activity.
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3.4. Test–Retest Reliability of GPAQ
There were 14 studies (i.e., 53.8%) that tested the reliability of the GPAQ (see Table 8). The research
design for these studies was similar, using a test–retest procedure to measure the consistency of the
GPAQ, which was similar to what has been reported in the literature [4,5]. The sample size ranged
from 16 to 940 and there was one study with a sample size smaller than 30. The reason for noting the
sample sizes was that Hogg et al. [49] pointed out that small samples (i.e., n < 30) for PA measures
tended to generate variability that is inappropriate to draw any conclusions on.
The test–retest reliability values varied from moderate to very good and only one study reported
poor reliability (r < 0.40). For the overall PA, the reliability was good to very good (r = 0.58–0.89).
Similar findings were found for the overall vigorous PA [VPA] and moderate PA [MPA]. When the
overall PA was converted into MET values, however, only moderate reliability was found. The
reliability range for work-related PA was about the same for the MPA (r = 0.41–0.99) and VPA (r
= 0.59–0.92). For transport and recreation PA domains, the reliability value ranges were about the
same. The time intervals for the short-term reliability ranged from three days to three weeks, and the
median value was seven days. Only one study had an interval of three days [36] and three weeks [43],
respectively. There were two long-term test–retest reliability studies with a two- (i.e., r-two month apart =
0.55) [12] and three-month interval (i.e., r-three month apart = 0.53) [42].
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Table 8. Summary of GPAQ test–retest reliability in different countries.
Country
(Author, Year)
Sample Size Days Apart Reliability Results
Overall PA MET Work Transport Recreation Sitting
China (Hu et al. 2015
[11])
205 participants, 38.54%
of males, aged 30–70
years
9 r = 0.81 r = 0.80
France (Rivière et al. 2018
[35])
92 students and staff in
a medical school, age
>18
7 r = 0.58 r = 0.67 Vigorous: r = 0.94;moderate: r = 0.37 r = 0.80
India (Misra et al. 2014
[36])
262 subjects, 116 (49.6%
male), age 15–65 years 3 r = 0.67 r = 0.68
Vigorous: r = 0.81;
moderate: r = 0.37 r = 0.72 r = 0.43
Korea (Lee et al. 2019
[46])
115 adults, aged 19–65
years, 48% male 7 r = 0.47 r = 0.27–0.47 r = 0.53 −0.70 r = 0.65
Malaysia (Soo et al. 2015
[37])
100 adults aged 20–58
years old 14 z = −0.450, p = 0.653
Vigorous: z = −0.093, p
= 0.926; moderate: z =
−0.733, p = 0.464
Vigorous-intensity: z =
0.445, p = 0.656;
moderate- intensity: z
= −3.515, p < 0.001






14 Vigorous: r = 0.78;Moderate: r = 0.44 r = 0.70
Singapore (Chu et al.
2015 [18])
110 working adults and
students 7 MVPA: r = 0.54
Vigorous: r = 0.59;
Moderate: r = 0.37 r = 0.47
Vigorous: r = 0.73;
moderate: r = 0.60
Singapore (Chu et al.
2018 [7])
84 medicine faculty and




group MVPA: r = 0.63
Moderate: r = 0. 55;
vigorous: r = 0.71 r = 0.47
Moderate: r = 0.46;
vigorous: r = 0.86
Interview-administered
group MVPA: r = 0.61 Moderate: r = 0.41 r = 0.73
Moderate: r = 0.59;
vigorous: r = 0.82
All MVPA: r = 0.63 Moderate: r = 0.48;vigorous: r = 0.71 r = 0.60
Moderate: r = 0.53;
vigorous: r = 0.83







Moderate to vigorous: r
= 0.78; Moderate: r =
0.73; Vigorous: r = 0.62
r = 0.44
US (Herrmann et al. 2013
[42])




(10) r = 0.89 Moderate: r = 0.87 r = 0.83
Moderate: r = 0.96;
vigorous: r = 0.90 r = 0.92
Study 2: 16 adults;
aged 18–65 years
Long terms
(3 months) r = 0.82
Moderate: r = 0.68;
vigorous: r = 0.74 r = 0.54
Moderate: r = 0.53;
vigorous: r = 0.74 r = 0.83




21 Male r = 0.32 r = 0.28 r = 0.18 r = 0.20
Female r = 0.13 r = 0.22 r = 0.24 r = 0.31
Vietnam (Trinh et al. 2009
[12])
169 adults aged 25–64
years
14 r = 0.69 Moderate: r = 0.63;vigorous: r = 0.62 Moderate: r = 0.64
Moderate: r = 0.74;
vigorous: r = 0.50 r = 0.69
Long term (two
months) r = 0.55
Moderate: r = 0.47;
vigorous: r = 0.68 Moderate: r = 0.55
Moderate: r = 0.32;
vigorous: r = 0.37 r = 0.50




Sample Size Days Apart Reliability Results
Overall PA MET Work Transport Recreation Sitting
Bangladesh, Brazil, China,
Ethiopia, India, Indonesia, Japan,
Portugal, and South Africa
(Bull et al. 2009 [1])





Moderate: r = 0.57;
vigorous: r = 0.72;
total: r = 0.58
r = 0.57 Moderate: r = 0.31
Shanghai, China
Moderate: r = 0.99;
vigorous: r = 0.92;
total: r = 0.99
r = 0.98
Moderate: r = 1.00;
vigorous: r = 1.00;
total: r = 1.00
Taiwan, China
Moderate: r = 0.40;
vigorous: r = 0.48;
total: r = 0.53
r = 0.54
Moderate: r = 0.50;
vigorous: r = 0.49;
total: r = 0.52
Ethiopia
Moderate: r = 0.50;
vigorous: r = 0.64;
total: r = 0.56
r = 0.53
Moderate: r = 0.52;
vigorous: r = 0.46;
total: r = 0.73
Indonesia
Moderate: r = 0.78;
vigorous: r = 0.68;
total: r = 0.80
r = 0.70
Moderate: r = 0.45;
vigorous: r = 0.61;
total: r = 0.52
Japan
Moderate: r = 0.85;
vigorous: r = 0.88;
total: r = 0.83
r = 0.90
Moderate: r = 0.83;
vigorous: r = 0.89;
total: r = 0.88
South Africa
Moderate: r = 0.75;
vigorous: r = 0.69;
total: r = 0.76
r = 0.75
Moderate: r = 0.77;
vigorous: r = 0.71;
total: r = 0.71
Note: MET = metabolic equivalent of task; PA = physical activity.
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4. Discussion
The importance of accurately monitoring PA levels on a regular basis in the general population
cannot be overstated. The current study contributed to our knowledge base by providing an overview
and synthesis concerning the reliability and validity of the GPAQ in different countries. The main
potential for this is to save billions of dollars in medical treatments caused by sedentary lifestyles and
increase one’s quality of life [5,50]. Overall, the highlighted findings were: (a) Inconsistent reliability
and validity among adults in free-living settings found in different countries, and (b) the lack of
revalidations in specific age groups as well as in other continents such as Africa, and North and South
America. Each of the highlights will be discussed in the following section.
4.1. GPAQ Reliability and Validity in Adults in Free-Living Settings
It is deemed critical to note the limitations of the GPAQ to help readers better understand the
findings that emerged from the systematic review. First, only self-reported data were used by the
GPAQ and some participants reported spending more than 8 h in work-related PA, which might not
be true unless they worked over-time. However, it is almost impossible to verify the accuracy of
the GPAQ data. Second, MVPA lasted for at least 10 min are measured by the GPAQ. It is possible
that the GPAQ may underestimate the total time spent in MVPA and cannot estimate the total PA.
Third, work-, transport-, and leisure-related PA can only be accurate when participants can clearly
differentiate among the three categories. Fourth, individuals who do not have a job will not be able
to report work-related PA. This may be the reason that the GPAQ has only been validated in adult
populations, thus limiting its ability to track or monitor individuals’ PA among children and youth.
And fifth, the GPAQ uses a typical week to estimate PA data. However, a typical week can be seasonal
in many developing countries [9,12], yielding different PA data.
4.1.1. Sample Size
Although there is no single rule of thumb related to adequate sample size for questionnaire
validation studies, scholars have recommended an acceptable ratio of survey items and participants to
be 1:5 and preferably 1:10 [28]. Therefore, the minimum sample size should be 90–160 and 95–190 for
the short and long versions of the GPAQ, respectively. However, about one-third of the revalidation
studies (i.e., 8 out of 23) had a sample size smaller than 100 and one study had a sample size smaller
than 30 (see Tables 5–7). This is a cause for concern as a smaller sample size may negatively affect the
representativeness of the population [4,28].
4.1.2. Concurrent Validity
To date, PA wearables are commonly used for testing the concurrent validity of self-reported
PA questionnaires [4,5,51]. Relatively low concurrent validity was found when Pearson’s r and/or
Spearman’s rho were calculated [34,40] using accelerometers as the criterion standard. This was
surprising, given accelerometers are typically found to be more accurate than pedometers [52], and
interesting enough, there were no large differences in concurrent validity results that were revealed
between studies using the two wearables (see Tables 5 and 6).
Such results may be explained by the following reasons. First, it might be caused by the
differences in measurement methods between the GPAQ and criterion-related measures. The GPAQ
is designed to ask participants about their PA and SB lasting for at least 10 min of MVPA excluding
light PA in a typical week. Accelerometers and pedometers, on the other hand, were used to
measure PA for the entire duration chosen by the researchers in the selected studies. Hence, the
week wearing accelerometers/pedometers may not be a typical week because no studies noted that a
typical PA week was chosen for participants to wear an accelerometer and/or pedometer or to use
a PA log. This means that the GPAQ data were not validated against the same measures obtained
from accelerometers/pedometers. Second, the inconsistency in PA measurements between the two
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methods must have resulted in errors in measuring PA. Accelerometers may underestimate upper
body movements and movements involve few vertical motions like cycling, as the accelerometers
were usually worn on the dominant hip of the participants [51]. Furthermore, studies have found
that pedometers may not accurately record steps for people with abnormal gait patterns and people
that are obese [53]. Pedometers also may not accurately capture activities in which the lower body is
stationary (i.e., pushing, lifting, and carrying). In fact, low concurrent validity using accelerometers and
pedometers as criteria has been found consistently in the literature, resulting from inherent limitations
of PA wearables serving as a ‘gold standard’ for self-report questionnaires [15]. Future validation
studies should include only bouts of at least 10 min of MVPA from accelerometer data to make it more
comparable to the GPAQ measuring activities lasting for at least 10 min.
There is a concern of using pedometer data as the criterion-related standard for testing GPAQ’s
concurrent validity in the reported studies (see Table 6). Pedometers measure steps without intensity
unless steps are recorded at a specific intensity, such as MPA steps, VPA step, or MVPA steps. Moreover,
unlike GPAQ, pedometers measure all steps. As such, steps per day recorded by pedometers are not
comparable to the MVPA time measured by GPAQ,
It is also important to point out the use of a previously validated self-reported questionnaire
such as the IPAQ as the comparison standard for concurrent validity [9,37,43] as it is not a true gold
standard. Many studies have shown the significant differences between data collected from the IPAQ
versus accelerometers [51]. In addition, the reason for developing and validating the GPAQ was that
the IPAQ-short form (IPAQ-SF) does not measure occupational, transport-related PA, which is the
dominant form of PA in many developing countries while the long form of IPAQ was deemed too long
and too complex to be used in studies with a large sample size [2,6]. Therefore, it is not surprising
that low concurrent validity would be found when IPAQ is used as the so-called gold standard in
developing countries. On the other hand, the use of PA logs as a criterion standard for concurrent
validity is also a cause for concern as GPAQ and PA log data are not comparable if a typical week of PA
is not measured. Unfortunately, none of the selected validation studies on the topic had noted that PA
data were measured using the criterion-related standard means during a typical PA week, which is
specified in GPAQ (see Table 4).
4.1.3. Reliability
It is encouraging that the range of reliability was found to be good to very good, except for only
one study with poor reliability (r < 0.30). Of greater importance, the time intervals for the test–retest
varied from three days to three weeks for short term-reliability or repeatability, which are within
the recommended range [28]. It is alarming, however, that the actual PA change in test–retest was
ignored by the two studies [42,43] on long-term repeatability/reliability (i.e., two or three months apart)
of the GAPQ without ensuring that participants’ PA pattern remained the same within the two- or
three-month time span. This methodological flaw in the research design made the findings dubious [4].
4.2. The Lack of Revalidations in Elderly Groups and Other Continents
4.2.1. Revalidation in Various Age Groups
It is surprising that a wide age range (i.e., 15–79) existed in the selected studies and no research
has specifically examined the reliability and validity of GPAQ in elderly adults. The following two
reasons are for the necessity of validating the GPAQ in elderly groups. First, age affects the accuracy of
self-reported PA due to the complexity in estimating PA patterns consisting of intensity, time, frequency,
and types [54]. Elderly individuals may not be able to correctly remember their typical PA levels. And
second, light/functional PA, which is not measured by GPAQ, plays an important role in the elderly’s
overall health [54,55]. This means that the current domain-specific PA (i.e., work, transportation, and
recreation) may not be suitable for the elderly considering that they usually do not have a job and only
perform limited functional PA.
Int. J. Environ. Res. Public Health 2019, 16, 4128 24 of 27
4.2.2. Revalidations of GPAQ in Other Continents
Although it has been noted that the GPAQ has been used in many African countries [2], it is unclear
why it has primarily been validated in Asia and Europe. Hence, this gap in knowledge warrants more
attention to professionals in the field of PA measurement and assessment. More validation studies
are needed in continents other than Asia and Europe in the future to ensure that the GPAQ is truly a
global PA scale.
4.3. Limitations
The present review has some limitations that should be acknowledged. Although we thoroughly
searched the aforementioned four largest databases in the fields of physical activity measurement and
assessment more than once by multiple investigators, it is still possible that not all relevant studies
have been identified using the search strategies described in the study. Even though the quality of
each study was assessed, they were not weighted or ranked. Thus, findings from studies with poorer
quality and smaller sample sizes were given no less importance than other findings. Caution needs
to be exercised when interpreting the results of the current project. Factors such as education level,
gender, seasons, and types of residential areas (i.e., rural, suburban, and urban) have been found to
affect the reliability and validity of GPAQ. Future research is needed on concurrent validity differences
in the above factors.
5. Conclusions
As a global instrument for measuring PA, the GPAQ has been translated into different languages
and validated among adults in more than 20 countries, primarily in Asia and Europe. The GPAQ
demonstrated good-to-very good test–retest reliability with time intervals that ranged from three
days to two weeks. Poor to fair concurrent validity was found when the GPAQ data were compared
to the data measured by PA wearables (i.e., accelerometers and pedometers) and PA logs for seven
days. Mixed findings were found concerning the effects of educational level and sex on the reliability
and validity of the GPAQ. Incomparable data were used to test the concurrent validity of the GPAQ
using the data measured by accelerometers, pedometers, and PA log. As such, it is premature to
draw any conclusions concerning the concurrent validity of the GPAQ. Great care must be taken into
consideration when interpreting the existing findings of GPAQ concurrent validity. Future research
should focus on validating the GPAQ with matching data measured by relatively objective tools such
as accelerometers and/or pedometers. More studies are needed to use bouts of at least 10 min of MVPA
from accelerometer data to make it more comparable to GPAQ data focusing on MVPA lasting for at
least 10 min.
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